Latest Shareholder Value News

Helix Resources has secured a $500,000 investment from Acta Investment Group, simplifying a proportional takeover and appointing Michael Povey as Executive Chair. Meanwhile, promising copper and gold exploration results from the Cobar region signal potential value creation for shareholders.

Revolver Resources has locked in A$500,000 through a 1% gross revenue royalty agreement on its Dianne Copper Mine Project, providing crucial non-dilutive funding as it advances toward production.

Sigma Healthcare has successfully passed all key resolutions at its extraordinary general meeting, clearing a major hurdle for its proposed merger with Chemist Warehouse. The deal now awaits final court approval, with implementation expected in February.

EUROZ HARTLEYS GROUP LIMITED has announced a fully franked ordinary dividend of AUD 0.020 per share for the six months ending December 2024, signaling steady shareholder returns.

Octava Minerals reports significant progress in its Western Australian exploration projects, completing initial drilling at Yallalong and metallurgical drilling at Byro, supported by a $1.25 million capital raise and the strategic sale of its Talga Project.

Hudson Investment Group signals potential corporate restructure as it explores sale and joint venture options for key Queensland and NSW properties.

Southern Cross Gold Consolidated Ltd. reported a significantly reduced net loss of $2.41 million for Q2 2024, down from $43.69 million a year earlier, as it sharpens focus on its Australian gold projects following a major corporate restructuring.

InVert Graphite Limited has secured shareholder approval for a transformative acquisition of a Tanzanian graphite project and rebranded from Dominion Minerals, positioning itself for a strategic relisting on the ASX.

Pure Hydrogen Corporation Limited is set to unlock value by spinning out its Australian gas assets into Eastern Gas Limited, offering shareholders free shares in the new entity. The move positions Eastern Gas to capitalize on strong East Coast gas market demand with an anticipated $8–10 million IPO.

Starpharma reports encouraging FDA feedback on its DEP® SN38 candidate for ovarian cancer and prepares for product launches in Saudi Arabia and UAE, supported by a solid $20.3 million cash position.

Austral Resources Australia Ltd reports steady operational progress and promising resource developments in its December 2024 quarter, while navigating an ongoing recapitalisation and leadership transition.

PVW Resources has appointed Lucas Stanfield as CEO, bringing rare earths project expertise to accelerate development of its Brazilian assets. Stanfield’s leadership marks a strategic pivot towards advancing critical mineral projects in a globally significant mining jurisdiction.